Dare Bioscience (DARE) Competitors $2.40 0.00 (0.00%) As of 07/7/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DARE vs. OKYO, JSPR, FBRX, CLLS, CLYM, CABA, MCRB, TCRX, VNRX, and SRZNShould you be buying Dare Bioscience stock or one of its competitors? The main competitors of Dare Bioscience include OKYO Pharma (OKYO), Jasper Therapeutics (JSPR), Forte Biosciences (FBRX), Cellectis (CLLS), Climb Bio (CLYM), Cabaletta Bio (CABA), Seres Therapeutics (MCRB), TScan Therapeutics (TCRX), VolitionRx (VNRX), and Surrozen (SRZN). These companies are all part of the "pharmaceutical products" industry. Dare Bioscience vs. Its Competitors OKYO Pharma Jasper Therapeutics Forte Biosciences Cellectis Climb Bio Cabaletta Bio Seres Therapeutics TScan Therapeutics VolitionRx Surrozen Dare Bioscience (NASDAQ:DARE) and OKYO Pharma (NASDAQ:OKYO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability. Which has more volatility & risk, DARE or OKYO? Dare Bioscience has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Comparatively, OKYO Pharma has a beta of -0.09, meaning that its share price is 109% less volatile than the S&P 500. Do institutionals and insiders have more ownership in DARE or OKYO? 6.7% of Dare Bioscience shares are held by institutional investors. Comparatively, 3.0% of OKYO Pharma shares are held by institutional investors. 4.0% of Dare Bioscience shares are held by insiders. Comparatively, 40.5% of OKYO Pharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media refer more to DARE or OKYO? In the previous week, Dare Bioscience had 1 more articles in the media than OKYO Pharma. MarketBeat recorded 1 mentions for Dare Bioscience and 0 mentions for OKYO Pharma. Dare Bioscience's average media sentiment score of 0.00 equaled OKYO Pharma'saverage media sentiment score. Company Overall Sentiment Dare Bioscience Neutral OKYO Pharma Neutral Do analysts recommend DARE or OKYO? Dare Bioscience currently has a consensus target price of $12.00, suggesting a potential upside of 400.00%. OKYO Pharma has a consensus target price of $7.00, suggesting a potential upside of 148.23%. Given Dare Bioscience's higher possible upside, research analysts plainly believe Dare Bioscience is more favorable than OKYO Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dare Bioscience 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50OKYO Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is DARE or OKYO more profitable? Company Net Margins Return on Equity Return on Assets Dare BioscienceN/A N/A -8.14% OKYO Pharma N/A N/A N/A Which has better valuation and earnings, DARE or OKYO? Dare Bioscience has higher revenue and earnings than OKYO Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDare Bioscience$10K2,124.00-$4.05M-$0.17-14.12OKYO PharmaN/AN/A-$16.83MN/AN/A SummaryDare Bioscience beats OKYO Pharma on 6 of the 9 factors compared between the two stocks. Get Dare Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DARE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DARE vs. The Competition Export to ExcelMetricDare BioscienceMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.24M$2.91B$5.52B$9.02BDividend YieldN/A2.44%5.24%4.08%P/E Ratio-14.1220.3027.1920.04Price / Sales2,124.00250.25413.81108.84Price / CashN/A41.7026.2128.59Price / Book-3.487.397.925.55Net Income-$4.05M-$55.04M$3.17B$248.49M7 Day Performance1.27%2.51%1.78%4.87%1 Month Performance-25.00%-0.21%1.26%6.63%1 Year Performance-22.33%3.41%33.30%20.38% Dare Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DAREDare Bioscience1.5673 of 5 stars$2.40flat$12.00+400.0%-23.8%$21.24M$10K-14.1230High Trading VolumeOKYOOKYO Pharma1.8292 of 5 stars$2.57+4.9%$7.00+172.4%+135.0%$82.90MN/A0.007Positive NewsJSPRJasper Therapeutics3.3823 of 5 stars$5.55+1.1%$59.25+967.6%-85.6%$82.47MN/A-1.0620News CoverageAnalyst ForecastGap DownFBRXForte Biosciences2.5394 of 5 stars$12.93+5.6%$61.00+371.8%+55,480.0%$80.65MN/A-0.795CLLSCellectis3.013 of 5 stars$1.53+5.2%$4.00+162.3%-21.6%$80.60M$49.22M-1.77290CLYMClimb Bio2.6152 of 5 stars$1.24+5.1%$9.00+625.8%N/A$79.74MN/A-0.529Positive NewsCABACabaletta Bio1.5049 of 5 stars$1.52-3.2%$14.43+849.2%-78.9%$79.67MN/A-0.6050MCRBSeres Therapeutics3.5245 of 5 stars$11.11+22.1%$73.67+563.1%-33.2%$79.46M$126.32M-2.42330Positive NewsGap DownHigh Trading VolumeTCRXTScan Therapeutics1.9567 of 5 stars$1.45+3.6%$7.80+437.9%-74.6%$79.23M$2.82M-1.33100VNRXVolitionRx1.6492 of 5 stars$0.76-9.3%$3.50+360.5%+8.6%$78.30M$1.31M-2.1180SRZNSurrozen2.3509 of 5 stars$8.94-0.9%$38.50+330.6%-15.2%$77.24M$10.65M-0.3680Gap DownHigh Trading Volume Related Companies and Tools Related Companies OKYO Pharma Alternatives Jasper Therapeutics Alternatives Forte Biosciences Alternatives Cellectis Alternatives Climb Bio Alternatives Cabaletta Bio Alternatives Seres Therapeutics Alternatives TScan Therapeutics Alternatives VolitionRx Alternatives Surrozen Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DARE) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dare Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dare Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
